The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s)

American Journal of Respiratory Cell and Molecular Biology

Volumn 41, Issue 5, 2009, Pages 573-582

  Chao, Jie ^a   Wood, John G ^a   Blanco, Victor Gustavo ^a   Gonzalez, Norberto C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar macrophages; Hypoxia; Mast cells; Monocyte chemoattractant protein; Systemic inflammation

Indexed keywords

CHEMOKINE; CYTOKINE; HYDROGEN PEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPOXIA; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MALE; MAST CELL; MAST CELL DEGRANULATION; MICROCIRCULATION; MICROSCOPY; NONHUMAN; OXYGEN TENSION; PERITONEUM MACROPHAGE; RAT; RESPIRATORY BURST;

ANIMALS; ANOXIA; CELL DEGRANULATION; CELLS, CULTURED; CHEMOKINE CCL2; CULTURE MEDIA, CONDITIONED; HYDROGEN PEROXIDE; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MALE; MAST CELLS; MICROCIRCULATION; OXYGEN; PARACRINE COMMUNICATION; PARTIAL PRESSURE; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; RESPIRATORY BURST; SPLANCHNIC CIRCULATION;

RATTUS;

EID: 70450179851     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0417OC     Document Type: Article

References (54)

1. Wood JG, Mattioli LF, Gonzalez NC. Hypoxia causes leukocyte adherence to mesenteric venules in non-acclimatized rats but not after acclimatization. J Appl Physiol 1999;86:873-881.
2. 2 and hypoxia-induced microvascular inflammation. J Appl Physiol 2003;94:2323-2329.
3. Dix R, Orth T, Allen J, Wood JG, Gonzalez NC. Activation of mast cells by systemic hypoxia, but not by local hypoxia, mediates increased leukocyte-endothelial adherence in cremaster venules. J Appl Physiol 2003;95:2495-2502. (Pubitemid 37444995)
4. Mc Donald JT, Gonzalez NC, Wood JG. Mast cell degranulation promotes the cerebral microvascular inflammatory response to hypoxia [abstract]. FASEB J 2003;17:A1282.
5. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol 1999;87:1734-1740.
6. Steiner DR, Gonzalez NC, Wood JG. Mast cells mediate the microvascular inflammatory response to hypoxia. J Appl Physiol 2003;94:325-334. (Pubitemid 36014328)
7. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia increases leukocyte emigration and vascular permeability in conscious rats. J Appl Physiol 2000;89:1561-1568.
8. Orth T, Allen J, Wood JG, Gonzalez NC. Plasma from conscious hypoxic rats stimulates leukocyte-endothelial interactions in normoxic cremaster venules. J Appl Physiol 2005;99:290-297. (Pubitemid 40934494)
9. Gonzalez NC, Allen J, Schmidt EJ, Casillan AJ, Orth T, Wood JG. Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol 2007;292:H2285-H2294. (Pubitemid 47084609)
10. Gonzalez NC, Allen JA, Blanco VG, Schmidt EJ, van Rooijen N, Wood JW. Alveolar macrophages are necessary for the systemic inflammation of acute alveolar hypoxia. J Appl Physiol 2007;103:1386-1394. (Pubitemid 47605978)
11. Lo LW, Koch CJ, Wilson DF. Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphyrin: a phosphor with general application for measuring oxygen concentration in biological systems. Anal Biochem 1996;236:153-160. (Pubitemid 126352768)
12. Shepherd RK, Duling BR. Use of ruthenium red staining to detect mast cell degranulation in vivo. Microcirculation 1995;2:363-370.
13. Poole TJ, Zetter BR. Stimulation of rat peritoneal mast cell migration by tumor-derived peptides. Cancer Res 1983;43:5857-5861. (Pubitemid 14212652)
14. Ferry X, Brehin S, Kamel R, Kandry Y. G protein-dependent activation of mast cells by peptides and basic secretagogues. Peptides 2002;23: 1507-1515. (Pubitemid 35223021)
15. Miyakazi M, Takai S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci 2006; 100:391-397. (Pubitemid 44609530)
16. Balcells E, Meng QC, Johnson WH Jr, Oparil S, Dell'Italia LJ. Angiotensin II formation form ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol Heart Circ Physiol 1997;273:H1769-H1774. (Pubitemid 27479276)
17. Yusof M, Kamada K, Gaskinf FS, Korthuis RJ. Angiotensin II mediates post-ischemic leukocyte-endothelial interactions: role of calcitonin gene-related peptide. Am J Physiol Heart Circ Physiol 2007;292: H3032-H3037. (Pubitemid 47084556)
18. Silver RB, Reid AC, Mackins CJ, Askwith T, Schaefer U, Herzlinger D, Levi R. Mast cells, a unique source of renin. Proc Natl Acad Sci USA 2004;101:13607-13612. (Pubitemid 39238450)
19. Mackins C, Kano S, Seyedi N, Schaefer U, Reid AC, Machida T, Silver AB, Levi R. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest 2006;116:1063-1070.
20. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004;287:R1014-R1030.
21. Ferrario CM, Strawn WB. Role of the renin-angiotensin system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98:121-126.
22. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling LL. NADPH oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 2002;4:899-914. (Pubitemid 36042466)
23. Ma J, Chen T, Mandelin J, Ceponis A, Miller NE, Hukkanen N, Ma GF, Konttinen YT. Regulation of macrophage activation. Cell Mol Life Sci 2003;60:2334-2346.
24. Gwinn MR, Vallyathan V Respiratory burst: role in signal transduction in alveolar macrophages. J Toxicol Environ Health B Crit Rev 2006;9: 27-39. (Pubitemid 43068297)
25. Iles KE, Forman HJ. Macrophage signaling and respiratory burst. Immunol Res 2002;26:95-105.
26. 2. J Clin Invest 1977;59:443-448.
27. Madjpour C, Jewell UR, Kneller S, Ziegler U, Schwenderer R, Booy C, Kläusli L, Pasch T, Schimmer RC, Beck-Schimmer B. Decreased alveolar oxygen induces lung inflammation. Am J Physiol Lung Cell Mol Physiol 2003;284:L360-L367. (Pubitemid 36164371)
28. Van Otteren GM, Standiford TJ, Kunkel SL, Danforth JM, Strieter RM. Alterations of ambient hypoxia modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1α from murine alveolar macrophages. Am J Respir Cell Mol Biol 1995;13:399-409.
29. Agorreta J, Zulueta JJ, Montuenga LM, Garayola M. Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS. Am J Physiol Lung Cell Mol Physiol 2005;288:L536-L545. (Pubitemid 40229520)
30. Leeper-Woodford SK, Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. Am J Physiol Lung Cell Mol Physiol 1999;276:L909-L913. (Pubitemid 29321167)
31. Vuichard D, Ganter MT, Schimmer RC, Suter D, Booy C, Reyes L, Pasch T, Beck-Schimmer B. Hypoxia aggravates lipopolysaccharide-induced injury. Clin Exp Immunol 2005;141:248-260.
32. deBoer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken H, Hiemstra P. Monocyte chemoattractant protein-1, interleukin-8 and chronic airways inflammation in COPD. J Pathol 2000;190:619-626.
33. Mc Courtei AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Szabo C, Mulligan MS. Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. Exp Mol Pathol 2008;84:141-144.
34. Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. The role of inflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2003;2003:261-272. (Pubitemid 36228304)
35. Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, Kron IL, Laubach VE. Alveolar macrophage activation is a key initiation signal for acute ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2006;291:L1018-L1026. (Pubitemid 44772064)
36. Frink M, Lu A, Thobe BM, Hsieh Y-C, Choudhry MA, Schwacha MG, Kunkel SL, Chaudry IH. Monocyte chemoattractant protein-1 influences trauma-hemorrhage- induced distal organ damage via regulation of keratinocyte-derived chemokine production. Am J Physiol Regul Integr Comp Physiol 2007;292:R1110-R1116. (Pubitemid 46377074)
37. Wan MX, Wang Y, Liu Q, Schramm R, Thorlacius H. CC chemokines induce P-selectin-dependent neutrophil rolling and recruitment in vivo: intermediary role of mast cells. Br J Pharmacol 2003;138: 698-706. (Pubitemid 36315318)
38. 3[H] 5HT release. Immunology 1995;86:434-440.
39. Ishii H, Hayashi S, Hogg JC, Fujii T, Goto Y, Sakamoto N, Mukae H, Vincent R, van Eeden SF. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Resp Res 2005;5:87. Available from: http://respiratory-research.com/content/6/1/87 (Pubitemid 41410150)
40. Van Eeden DF, Tan WC, Suwa T, Mukae H, Terashima T, Fuji T, Qui D, Vincent R, Hogg JC. Cytokines involved in the systemic in- flammatory response induced by particulate matter air pollutants. Am J Respir Crit Care Med 2001;164:826-830.
41. Agusti A, Soriano B. COPD as a systemic disease. COPD 2008;5:133-138.
42. Wüst RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:289-300. (Pubitemid 350110902)
43. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:1211-1218.
44. Tsantes A, Tassiopoulos S, Papadhimitriou SI, Bonovas S, Kavalierou L, Vaiapoulos G, Meletis I. Suboptimal erythropoietic response to hypoxemia in idiopathic pulmonary fibrosis. Chest 2003;124:548-553. (Pubitemid 37000132)
45. Morgan BJ. Vascular consequences of intermittent hypoxia. Adv Exp Med Biol 2007;618:69-84.
46. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P, LeJemtel TH. Inflamation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008;117:2270-2278.
47. Yende S, D'Angelo J, Kellum JA, Weissfeld L, Fine J, Welch RD, Kong L, Carter M, Angus DC. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008;177:1242-1247. (Pubitemid 351860933)
48. Fernandez-Serrano S, Dorca J, Coromines M, Carratala J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 2003;10:813-820. (Pubitemid 37129493)
49. Basnyat B,Murdoch BR. High altitude illnesses. Lancet 2003;361:1967-1974.
50. Hartmann C, Tschopp M, Fischer R, Bidlingmaier C, Riepl R, Tschopp K, Hartmann H, Endres S, Toepfer M. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000;12:246-252. (Pubitemid 30449882)
51. Beidleman BA, Muza SR, Fulco CS, Cymerman A, Staab JE, Sawka MN, Lewis SF, Skrinar GS. White blood cell and hormonal responses to 4300 m altitude before and after intermittent altitude exposure. Clin Sci (Lond) 2006;111:163-169. (Pubitemid 44220530)
52. Klausen T, Olsen NV, Poulsen TD, Richalet JP, Pedersen BK. Hypoxemia increases serum interleukin-6 in humans. Eur J Appl Physiol Occup Physiol 1997;76:480-482. (Pubitemid 27458422)
53. Wright AD. Medicine at high altitude. Clin Med 2006;6:604-608.
54. Michiels C, Arnaud T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2000;1497:1-10. (Pubitemid 30330885)